Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03800901 · ClinicalTrials.gov registry record · NA

Quality IQ Patient Simulation Physician Practice Measurement and Engagement

A NA study of Depression and Hypertension, sponsored by Qure Healthcare.

Completed
Registry status
NA
Development phase
187
Enrollment target
1
Study location

NCT03800901 is a NA study of Depression and Hypertension that has completed, run by Qure Healthcare. The registered enrollment target is 187 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03800901, a NA study of Depression and Hypertension, has completed, sponsored by Qure Healthcare.

COMPLETED
Registry status
NA
Development phase
187 participants
Enrollment target
1
Study location

Study Summary

This study will test the quality of physician care decisions using a patient-simulation based measurement and feedback approach that combines multiple-choice care decisions with real-time, personalized scoring and feedback. The study will also measure the impact of gaming-inspired competition and motivation, including a weekly leaderboard, to improve evidence-based care decisions. In addition, the study the test the impact of CME and MOC credits on participant engagement in the process.

Interventions

  • OTHER Continuing Medical Education
  • OTHER Quality IQ Patient Simulations

Study Locations (1)

California

  • QURE Healthcare - San Francisco

Trial Details

FieldValue
Enrollment Target 187 participants
Start Date 2019-01-11
Est. Completion 2019-04-15
Phase NA

Sponsor

Qure Healthcare

21 total trials

What the Registry Record Tells You About NCT03800901

The ClinicalTrials.gov registry entry for NCT03800901 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 187 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (76% lower). The listed sponsor is Qure Healthcare, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Continuing Medical Education is the first listed.

NCT03800901 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03800901 about?

NCT03800901 is a clinical study titled "Quality IQ Patient Simulation Physician Practice Measurement and Engagement". This study will test the quality of physician care decisions using a patient-simulation based measurement and feedback approach that combines multiple-choice care decisions with real-time, personalized scoring and feedback. The study will also measure the impact of gaming-inspired competition and mo...

What is the current status of trial NCT03800901?

This trial is currently completed. It is a NA study. The enrollment target is 187 participants. The study started on 2019-01-11. Estimated completion is 2019-04-15.

What conditions does trial NCT03800901 study?

This clinical trial studies the following conditions: Depression, Hypertension, Heart Failure, Asthma, Pain.

What interventions are being tested in trial NCT03800901?

The interventions under investigation include: Continuing Medical Education (OTHER), Quality IQ Patient Simulations (OTHER).

Who is sponsoring clinical trial NCT03800901?

This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03800901 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.